Ampio Pharmaceuticals, Inc.
Other OTCTotal Valuation
Ampio Pharmaceuticals, Inc. carries a market capitalization of 207,884.00, placing it among publicly traded companies globally. Its enterprise value stands at -2.23M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 207,884.00 |
| Enterprise Value | -2.23M |
Share Statistics
Ampio Pharmaceuticals, Inc. currently has 833,430.00 shares outstanding.
| Shares Outstanding | 833,430.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.01 |
| P/TBV Ratio | 0.47 |
| P/FCF Ratio | -0.18 |
| P/OCF Ratio | -0.18 |
Financial Position
Ampio Pharmaceuticals, Inc. maintains a current ratio of 2.41, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.41 |
| Quick Ratio | 2.11 |
| Debt / Equity | 8.15 |
| Debt / EBITDA | -0.03 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -89.34 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Ampio Pharmaceuticals, Inc.'s stock has gained approximately 6003.33333% over the past 52 weeks. The 50-day moving average sits at 0.16, while the 200-day moving average is 0.10.
| Beta (5Y) | N/A |
| 52-Week Price Change | 6003.33333% |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.10 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -9.40M, while operating income came in at -9.52M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -9.52M |
| Pretax Income | -8.63M |
| Net Income | -8.63M |
| EBITDA | -9.40M |
| EBIT | -9.52M |
| Earnings Per Share (EPS) | -11.19 |
Balance Sheet
Ampio Pharmaceuticals, Inc. holds 4.09M in cash and equivalents against 274,000.00 in total debt, resulting in a net debt position of -4.09M. Total book value stands at -242.53M, with working capital of 3.36M providing operational flexibility.
| Cash & Cash Equivalents | 4.09M |
| Total Debt | 274,000.00 |
| Net Debt | -4.09M |
| Equity (Book Value) | -242.53M |
| Book Value Per Share | -314.49 |
| Working Capital | 3.36M |
Cash Flow
Ampio Pharmaceuticals, Inc. produced -8.56M in operating cash flow over the past twelve months.
| Operating Cash Flow | -8.56M |
| Capital Expenditures | N/A |
| Free Cash Flow | -8.56M |
| FCF Per Share | -11.11 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | N/A |
| FCF Yield | -541.71 |
Stock Splits
Ampio Pharmaceuticals, Inc.'s most recent stock split took place on September 12, 2023 with a 20:1 split ratio.
| Last Split Date | 9/12/2023 |
| Split Ratio | 20:1 |
Scores
Ampio Pharmaceuticals, Inc. posts an Altman Z-Score of -63.57, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -63.57 |